血管免疫母细胞性淋巴结病15例临床病理分析

A clinicopathological analysis of 15 cases of angioimmunoblastic lymphadenopathy

分析１５例血管免疫母细胞性淋巴结病，认为小剂量强的松可用于诊断性治疗；提出将该病分为Ｂ免疫母细胞型、Ｔ免疫母细胞型及Ｂ和Ｔ免疫母细胞混合型３个组织学亚型；认为该病预后可能与诊断早晚、治疗用药是否恰当及时有关。

Fifteen patients with angioimmunoblastic lymphadenopathy(AIL) have been observed and analyzed by reviewing available clinical and pathological data. The results suggest that AIL is not an uncommon disorder in our country; it can be classified into three different groups: B immunoblastic,T immunoblastic type,and mixed immunoblastic type; its prognosis is related to the early or late diagnosis and therapy selection. Diagnostic therapy with a small dosage of cortisone is an useful method to diagnose AIL. Seven patients were mainly treated by a small dosage of cortisone(5～10 mg/day) insistently with satisfactory result.